Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)
jRCT2051200123Phase 1Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AK-1830, sponsored by Asahi Kasei Corporation. Primary endpoint: Plasma concentration of compound(s). Started Feb 2021; status: completed.
02
Drugs
AK-1830
Beyond the preview
Go deeper on jRCT2051200123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200123.